mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach

The U.S. Food and Drug Administration (FDA) has recently issued an Emergency Use Authorization (EUA) for 2 highly effective coronavirus disease 2019 (COVID-19) vaccines from Pfizer-BioNTech and Moderna. This has brought hope to millions of Americans in the midst of an ongoing global pandemic. The FD...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Allergy Clin Immunol Pract
Main Authors: Banerji, Aleena, Wickner, Paige G., Saff, Rebecca, Stone, Cosby A., Robinson, Lacey B., Long, Aidan A., Wolfson, Anna R., Williams, Paul, Khan, David A., Phillips, Elizabeth, Blumenthal, Kimberly G.
Format: Artigo
Jezik:Inglês
Izdano: American Academy of Allergy, Asthma & Immunology 2021
Teme:
Review and Feature Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948517/
https://ncbi.nlm.nih.gov/pubmed/33388478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2020.12.047
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki